Sign in
Taking peopleNo phase

Postoperative Outcomes of a Toric AddOn Intraocular Lens After Keratoplasty and Cataract Surgery

Key facts

Who runs it
Medical University of Vienna
Where
Austria1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
40 people, planned
Started
27 Aug 2026
Expected to end
Feb 2029
Type of study
Observational
Treatments tested
  • AddOn toric IOL implantation
Record updated
4 September 2026

Who can take part

Age
45 years to 95 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 16 criteriaShow less

Who can take part

  • Gender: female, male, or diverse
  • Ophthalmological diagnosis: pseudophakic patients after keratoplasty
  • Age: 45 to 95 years
  • Complication-free cataract surgery using phacoemulsification and implantation of a posterior chamber lens
  • Complication-free keratoplasty and regular postoperative corneal astigmatism > 1 diopter (D)
  • Pupil diameter in mydriasis > 5.5 mm

Who cannot take part

  • History of uveitis or iritis
  • Uncontrolled systemic or ocular disease
  • Uncontrolled glaucoma
  • Proliferative diabetic retinopathy
  • Iris neovascularization
  • Microphthalmus
  • Recurrent intraocular inflammation of unknown cause
  • Blindness in the other eye
  • Pregnancy
  • Breastfeeding

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 45 and 95 years old?

This trial is currently available in Austria.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The aim of this clinical study is to evaluate a toric add-on intraocular lens (IOL) for the correction of high astigmatism in patients who have undergone keratoplasty and cataract surgery. As this patient group often suffers from significant preoperative residual astigmatism, there is a relevant clinical need for effective and safe refractive treatment options. The implantation of a toric add-on IOL in the ciliary sulcus is intended to significantly reduce postoperative astigmatism and improve visual rehabilitation.

Read full original descriptionShow less

The study is designed as a prospective, monocentric clinical trial with a limited number of cases, as this is a rare condition with limited availability of suitable patients. It is being conducted in accordance with Section 3 of the Austrian Medical Devices Act (MPG 2021) and is investigating a CE-marked add-on intraocular lens implant used within its intended purpose. The postoperative refractive cylinder serves as the primary endpoint, as it reflects the actual effectiveness of astigmatism correction. The rotational stability of the add-on IOL, which significantly influences refractive precision, is recorded as a secondary endpoint.

All study participants will be examined pre- and postoperatively in accordance with applicable medical standards. The results should contribute to the optimization of refractive care after keratoplasty and assess the clinical applicability of toric AddOn IOLs in this specific indication.

Treatments tested

  • AddOn toric IOL implantation

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Postoperative Outcomes of a Toric Add-On Intraocular Lens After Keratoplasty and Cataract Surgery
Criteria questions
Built from NCT07452042, who can take part
Record updated
4 September 2026